Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non-Current Assets (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Other Non-Current Assets for 4 consecutive years, with $35000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Non-Current Assets fell 25.53% year-over-year to $35000.0, compared with a TTM value of $35000.0 through Sep 2023, down 25.53%, and an annual FY2022 reading of $37000.0, down 60.64% over the prior year.
  • Other Non-Current Assets was $35000.0 for Q3 2023 at Terns Pharmaceuticals, down from $36000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $246000.0 in Q4 2020 and bottomed at $35000.0 in Q3 2023.
  • Average Other Non-Current Assets over 4 years is $98916.7, with a median of $68000.0 recorded in 2022.
  • The sharpest move saw Other Non-Current Assets plummeted 72.19% in 2022, then dropped 25.53% in 2023.
  • Year by year, Other Non-Current Assets stood at $246000.0 in 2020, then plummeted by 61.79% to $94000.0 in 2021, then tumbled by 60.64% to $37000.0 in 2022, then fell by 5.41% to $35000.0 in 2023.
  • Business Quant data shows Other Non-Current Assets for TERN at $35000.0 in Q3 2023, $36000.0 in Q2 2023, and $37000.0 in Q1 2023.